NHS weight loss injections: eligibility, costs, and safe access guide (2026)

Medical weight management has changed considerably in the UK, with injectable treatments now forming a recognised part of obesity care. These medications work by mimicking hormones that regulate appetite, helping people reduce calorie intake and, over time, achieve meaningful weight loss when combined with lifestyle changes. But access, eligibility, and cost vary widely depending on your circumstances and location.

NHS eligibility criteria for weight loss injections in 2026

NHS eligibility for weight loss injections in England is currently guided by specific criteria set by the National Institute for Health and Care Excellence (NICE). To qualify, patients generally need a BMI of 35 or above, alongside at least one weight-related health condition such as type 2 diabetes, high blood pressure, or sleep apnoea. In some cases, individuals from certain ethnic backgrounds may qualify at a lower BMI threshold, as these groups face higher health risks at lower body weights. Meeting the criteria does not automatically guarantee immediate access, as NHS availability remains subject to local commissioning decisions and specialist service capacity.

GP referrals, specialist services, and regional access pathways

Accessing weight loss injections through the NHS typically begins with a GP referral to a specialist weight management service or a tier 3 obesity clinic. These services assess patients holistically, considering medical history, previous weight loss attempts, and readiness for lifestyle change. Regional access pathways differ across England, Scotland, Wales, and Northern Ireland, meaning that where you live can significantly influence how quickly you are seen and what treatments are offered. Waiting times for specialist services can be lengthy in some areas, which leads many patients to explore private options.

Estimated NHS and private treatment costs

NHS-prescribed weight loss injections are dispensed at the standard prescription charge, currently £9.90 per item in England as of 2025, with free prescriptions available for those who qualify. However, because these medications are typically prescribed through specialist pathways rather than standard GP prescriptions, NHS patients do not always pay out of pocket. Private treatment costs are considerably higher and vary by provider and medication. Below is a general overview of estimated private costs for weight loss injections in the UK.

Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.

Wegovy, Mounjaro, and Saxenda under medical supervision

All three medications currently available in the UK work differently but share the goal of supporting weight reduction under medical supervision. Wegovy contains semaglutide and is specifically licensed for chronic weight management. Mounjaro contains tirzepatide and was originally developed for type 2 diabetes management but has received wider approval for weight loss use in the UK. Saxenda uses liraglutide and has been available longer than the newer options. Each medication requires gradual dose escalation to minimise side effects, and all should only be used as part of a broader programme that includes dietary guidance and increased physical activity.

Safety checks, regulated providers, and lifestyle support

One of the most important considerations when accessing weight loss injections, particularly through private or online routes, is ensuring the provider is properly regulated. In the UK, legitimate providers must be registered with the Care Quality Commission (CQC) in England or equivalent bodies in other nations. Any prescribing should involve a qualified prescriber who conducts a thorough medical assessment, including reviewing existing conditions and medications. Reputable services also offer ongoing monitoring and lifestyle support rather than simply supplying medication without follow-up. Patients should be cautious of unregulated online sources that bypass clinical checks entirely, as counterfeit or improperly stored medications pose serious health risks.

Navigating weight loss injection options in the UK requires a clear understanding of eligibility requirements, realistic expectations about NHS access timelines, and careful evaluation of private providers if that route is being considered. Whether accessed through the NHS or privately, these treatments are most effective when delivered alongside structured lifestyle support and regular clinical oversight.